Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II

被引:121
作者
Miller, JA [1 ]
Thai, K [1 ]
Scholey, JW [1 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
glomerular filtration rate; renal blood flow; mean arterial pressure; aldosterone; losartan; angiotensin II;
D O I
10.1046/j.1523-1755.1999.00770.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Most of the known actions of angiotensin II (Ang II) are mediated by the Ang II type 1 receptor (AGT(1)R). A noncoding polymorphism of the AGT(1)R gene has been described in which there is either an adenine (A) or cytosine (C) base at position 1166, The functional significance of this polymorphism is unknown, prompting us to examine the relationship between this polymorphism and the systemic and renal responses to AGT(1)R blockade and subpressor Ang II infusion. Methods. Sixty-six healthy Caucasian men and women, genotyped for the AGT(1)R polymorphism by polymerase chain reaction, were chosen to form two homogeneous groups: AA and AC/CC. Renal hemodynamic function was assessed with inulin and para-aminohippurate clearance before and after AGT(1)R receptor blockade with losartan and Ang II infusion. Results. The mean values at baseline for glomerular filtration rate (GFR), renal plasma flow (ERPF), and renal blood flow (RBF) were significantly lower in the AC/CC group compared with the AA group. Losartan increased the GFR and decreased the mean arterial pressure (MAP) in the AC/CC group, but did not influence these parameters in the AA group. The aldosterone responses to losartan were blunted in the AA subgroup. During Ang TT infusion, AC/CC subjects maintained GFR despite equivalent declines in RBF, suggesting an enhanced efferent arteriolar constrictive response. Conclusions. Taken together, these results suggest that there is a relationship between the AGT(1)R A(1166)-->C polymorphism and the humoral and renal hemodynamic responses to AGT(1)R blockade and to Ang II infusion in the sodium-replete state, and that the C allele is associated with enhanced intrarenal and peripheral Ang II activity. Further studies are required to determine the genetic locus for this effect.
引用
收藏
页码:2173 / 2180
页数:8
相关论文
共 50 条
  • [41] The Angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor - Mediated hypertrophy
    D'Amore, A
    Black, MJ
    Thomas, WG
    HYPERTENSION, 2005, 46 (06) : 1347 - 1354
  • [42] Localization of angiotensin II type 1 receptor gene expression in rodent and human kidneys
    Schrankl, Julia
    Fuchs, Michaela
    Broeker, Katharina
    Daniel, Christoph
    Kurtz, Armin
    Wagner, Charlotte
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (04) : F644 - F653
  • [43] Apelin Receptor is an Allosteric Inhibitor of the Angiotensin II Type 1 Receptor
    Smith, Layton H.
    Siddiquee, Khandaker
    Hampton, Jessica
    CIRCULATION, 2011, 124 (21)
  • [44] Dietary salt intake modulates angiotensin II type 1 receptor gene expression
    Schmid, C
    Castrop, H
    Reitbauer, J
    DellaBruna, R
    Kurtz, A
    HYPERTENSION, 1997, 29 (04) : 923 - 929
  • [45] Effects of angiotensin II type 1 receptor antagonist, losartan, on ventilatory response to exercise and neurohormonal profiles in patients with chronic heart failure
    Kinugawa, T
    Kato, M
    Ogino, K
    Osaki, S
    Igawa, O
    Hisatome, I
    Shigemasa, C
    JAPANESE JOURNAL OF PHYSIOLOGY, 2004, 54 (01) : 15 - 21
  • [46] Novel regulations of the angiotensin II receptor type 1 by calmodulin
    Ehlers, Kevin
    Clements, Robert
    VerMeer, Mark
    Giles, Jennifer
    Tran, Quang-Kim
    BIOCHEMICAL PHARMACOLOGY, 2018, 152 : 187 - 200
  • [47] Angiotensin II type 1 receptor blockade in early cirrhosis
    Castano, Gustavo O.
    Sookoian, Silvia C.
    JOURNAL OF HEPATOLOGY, 2007, 47 (03) : 426 - 427
  • [48] The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior
    Olschewski, Daniel Navin
    Hofschroer, Verena
    Nielsen, Nikolaj
    Seidler, Daniela G.
    Schwab, Albrecht
    Stock, Christian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (06) : 2560 - 2576
  • [49] Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?
    Michele A. Tedesco
    Gennaro Ratti
    Giovanni Di Salvo
    Francesco Natale
    Drugs & Aging, 2002, 19 : 723 - 732
  • [50] Angiotensin II type 2 receptor gene polymorphisms and essential hypertension
    Zhang, Y
    Zhang, KX
    Wang, GL
    Huang, W
    Zhu, DL
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (11) : 1089 - 1093